The American habit of impulse buying
Blame the thrill of the splurge: One in five shoppers has shelled out more than $1,000 on a spur-of-the-moment purchase
Watch CBS News
Aimee Picchi is associate managing editor for CBS MoneyWatch, where she covers business and personal finance. She previously worked at Bloomberg News and has been published by national news outlets including USA Today and Consumer Reports. Aimee frequently writes about retirement, and has been a National Press Foundation fellow for reporting on retirement and Columbia University's Age Boom Academy. She's also the editor of the Institutional Investor book "Cultivating the Affluent II," with noted wealth consultant Russ Alan Prince.
Blame the thrill of the splurge: One in five shoppers has shelled out more than $1,000 on a spur-of-the-moment purchase
For companies, the link between financial performance and the health of workers is clear -- should investors demand details?
When major winter storms hit, Americans typically stock up on these items, but they can forget some essentials
British court told the candy maker to give it a break in its request to protect the four-finger bar
It may seem like an odd match, but the broadcaster says comedy is the best way to reach millennials
The retail giant's high hopes for the small-format stores seemed well placed, until reality created another story line
Office workers, beware: the "Fourth Industrial Revolution" could spell doom for your career
The richest have seen their wealth jump by 44 percent since 2010, while the bottom half has lost ground
Since 1980, one luxury product has enjoyed higher returns, but there may be no accounting for taste
You've heard plenty of anecdotes about grads stuck in low-paying service jobs, but here's what's really happening
It takes employers only minutes to tell if a candidate is hirable, thanks to these faux pas
Workers in some regions of the U.S. have much lower access to a retirement plan, making it hard for them to save
The fitness device maker has been suffering in 2016, with its stock slipping below its IPO price
Big pharma is busily raising prices on dozens of medications, branded and generic, with increases of 20 percent or more
Those 18 to 34 years olds are key to making the health insurance plan work, but so far their numbers are falling short